Abstract
The epidemiology of human papillomavirus (HPV)-related cancers has changed significantly over recent decades. Both international and Estonian data demonstrate an increasing incidence of non-cervical HPV-related malignancies, particularly oropharyngeal and anal cancers. This shift does not indicate a reduction in disease burden, but rather its redistribution across different anatomical sites. Effective cancer prevention requires an integrated, datadriven approach that unites vaccination, screening, diagnostics, treatment, and follow-up. The aim of this review article is to examine the changing epidemiology of HPV-related cancers, emerging risks, and prevention strategies in Estonia.